-2-toluidino)-1%2C3%2C5-triazin-2-ylamino)-1-hydroxy-2-(4-methoxy-2-sulphonatophenylazo)naphthalene-3-sulphonate%20DRIMAREN%20SCHARLACH%20X-GA%20979%3B%20DRIMAREN%20SCHARLAKEN%20X-GA%3B%20DRIMAREN%20SCHARLAKEN%20X-GA%20979%3B%20DRIMARENE%20SCARLET%20X-2%20GN%3B%20ECARLATE%20DRIMARENE%20X-2GN%3B%20ECARLATE%20DRIMARENE%20X-GA%20979%3B%20ECARLATE%20X-GA%20979%3B%20SCARLET%20X-GA%20979%20016-038-00-6.png)
disodium 6-((4-chloro-6-( N -methyl)-2-toluidino)-1,3,5-triazin-2-ylamino)-1-hydroxy-2-(4-methoxy-2-sulphonatophenylazo)naphthalene-3-sulphonate DRIMAREN SCHARLACH X-GA 979; DRIMAREN SCHARLAKEN X-GA; DRIMAREN SCHARLAKEN X-GA 979; DRIMARENE SCARLET X-2 GN; ECARLATE DRIMARENE X-2GN; ECARLATE DRIMARENE X-GA 979; ECARLATE X-GA 979; SCARLET X-GA 979 016-038-00-6
Name
disodium 6-((4-chloro-6-( N -methyl)-2-toluidino)-1,3,5-triazin-2-ylamino)-1-hydroxy-2-(4-methoxy-2-sulphonatophenylazo)naphthalene-3-sulphonate DRIMAREN SCHARLACH X-GA 979; DRIMAREN SCHARLAKEN X-GA; DRIMAREN SCHARLAKEN X-GA 979; DRIMARENE SCARLET X-2 GN; ECARLATE DRIMARENE X-2GN; ECARLATE DRIMARENE X-GA 979; ECARLATE X-GA 979; SCARLET X-GA 979 016-038-00-6
Identifiers
cas number 86393-35-3 PRIMARY
ec number 400-380-1
chemical name 2-Naphthalenesulfonic acid, 7-[[4-chloro-6-[methyl(2- methylphenyl)amino]-1,3,5-triazin-2-yl]amino]-4-hydroxy -3-[(4-methoxy-2-sulfophenyl)azo]-, disodium salt
chemical name disodium 6-((4-chloro-6-( N -methyl)-2-toluidino)-1,3,5-triazin-2-ylamino)-1-hydroxy-2-(4-methoxy-2-sulphonatophenylazo)naphthalene-3-sulphonate DRIMAREN SCHARLACH X-GA 979; DRIMAREN SCHARLAKEN X-GA; DRIMAREN SCHARLAKEN X-GA 979; DRIMARENE SCARLET X-2 GN; ECARLATE DRIMARENE X-2GN; ECARLATE DRIMARENE X-GA 979; ECARLATE X-GA 979; SCARLET X-GA 979 016-038-00-6
GHS Hazard Pictograms
GHS07 Hazard Classifications
Skin Sens. 1
Warning
Skin sensitisation
Hazard Code: H317
Category: Skin Sens. 1
Source: Harmonised C&L
Regulatory Lists (1)
KEMI PRIO PHASE-OUT SUBSTANCES
KEMI PRIO Phase-Out Substances — Swedish Chemicals Agency list of substances with properties of very high concern that should be phased out
Disclaimer
The substance data provided is sourced from various third-party databases and regulatory sources. While we strive to maintain accuracy, we cannot guarantee the completeness, accuracy, or timeliness of this information. Users are responsible for verifying all data before use in compliance, safety, or regulatory contexts. NextSDS is not liable for any decisions made based on this data.